Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The new U.S. National Osteoporosis Foundation Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck (FN), or spine BMD T-scores ≤−2.5 and presence of low bone mass at the FN or spine plus a 10-yr risk of hip fracture ≥3% or of major osteoporotic fracture ≥20%. The proportion of women who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to women participating in the Study of Osteoporotic Fractures (SOF). To determine how the SOF population differs from the general U.S. population of white women ≥65 yr of age, we compared women in SOF with women who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, women in SOF had higher FN BMD and were younger. Application of NOF guidelines to SOF data estimated that at least 72% of U.S. white women ≥65 yr of age and 93% of those ≥75 yr of age would be recommended for drug treatment. Application of the new NOF Guidelines would result in recommending a very large proportion of white women in the United States for pharmacologic treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595 · cited 1×
“Participants were recruited from population-based listings and mass mailings between 1986 and 1987.((6)) SOF was initiated before widespread publicity about osteoporosis and women were not recruited on the basis of any risk factors for osteoporosis.”
MethodSelf-citationFRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467
Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 2×
“5).((15)) Moreover, in the risedronate hip study, no clear fracture reduction benefit compared with placebo was noted among women 80 yr of age who were selected on the basis of risk factors and not BMD.”
BackgroundSelf-citationEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Updated Data on Proximal Femur Bone Mineral Levels of US Adults
Looker, A. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., Johnston Jr, C. C., & Lindsay, R. (1998) · Osteoporosis International · doi:10.1007/s001980050093 · Cited by 1,121 · cited 5×
“A direct estimation of the proportion of white women 65 yr of age who would be recommended for treatment under the NOF guidelines cannot be performed using NHANES III because lumbar spine BMD, paternal history of fracture, and personal history of fracture at skeletal sites other than the hip, spine, and wrist were not…”
MethodInfluentialMacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00198 · Cited by 529
Cost-effective osteoporosis treatment thresholds: the United States perspective
Tosteson, A. N. A., Melton, L. J., Dawson-Hughes, B., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0550-6 · Cited by 441
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0559-5 · Cited by 427 · cited 1×
“Although the NOF cost-effectiveness analysis did not report the proportion of women who would be treated under the NOF guidelines, they do conclude that pharmacologic treatment would be cost-effective for the average 68-yr-old white woman.((10)) Thus, given that the average age of women who participated in SOF was 71…”
Background
Cited by
Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
Schwartz, A. V. (2011) · JAMA · doi:10.1001/jama.2011.715 · Cited by 717
Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW
Compston, J. E., Watts, N. B., Chapurlat, R., Cooper, C., Boonen, S., Greenspan, S., Pfeilschifter, J., Silverman, S., Díez-Pérez, A., Lindsay, R., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.06.013 · Cited by 552
Vilarrasa, N., San José, P., García, I., Gómez-Vaquero, C., Medina Miras, P., de Gordejuela, A. G. R., Masdevall, C., Pujol, J., Soler, J., & Gómez, J. M. (2011) · Obesity Surgery · doi:10.1007/s11695-010-0338-1 · Cited by 129
Is Osteoporosis Disease Management Cost Effective?
Dell, R., & Greene, D. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0009-0 · Cited by 54
Conflicts at the heart of the FRAX tool
Järvinen, T. L. N., Jokihaara, J., Guy, P., Alonso-Coello, P., Collins, G. S., Michaëlsson, K., & Sievänen, H. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.121874 · Cited by 37
Metadata
- Authors
- Donaldson, M. G., Cawthon, P. M., Lui, L.-Y., Schousboe, J. T., Ensrud, K. E., Taylor, B. C., Cauley, J. A., Hillier, T. A., Black, D. M., Bauer, D. C., & Cummings, S. R.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-01
- Volume
- 24
- Issue
- 4
- Pages
- 675-680
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2092693917
- Cited by
- 106
- References
- 9
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines. https://app.cochat.ai/papers/10.1359/jbmr.081203
- The paper
- Donaldson, M. G., Cawthon, P. M., Lui, L.-Y., Schousboe, J. T., Ensrud, K. E., Taylor, B. C., Cauley, J. A., Hillier, T. A., Black, D. M., Bauer, D. C., & Cummings, S. R. (2009). Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.081203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.